Blue Door Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Blue Door Asset Management's IBB Position: Q2 2022 in Review
Blue Door Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 10,845 shares — an estimated $1.41M sold.
Blue Door Asset Management first reported a position in IBB in Q4 2021 and held it in 2 quarters. The position peaked at $1.66M in Q4 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.
- Blue Door Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
- Blue Door Asset Management sold 10,845 iShares Biotechnology ETF shares in Q2 2022, an estimated $1.41M.
- Blue Door Asset Management first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 2 quarters.
- Blue Door Asset Management's iShares Biotechnology ETF position peaked at $1.66M in Q4 2021.
- 858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.
Based on Blue Door Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.